Printer Friendly

QUIDEL AND BECTON DICKINSON CROSS LICENSE TECHNOLOGY

 QUIDEL AND BECTON DICKINSON CROSS LICENSE TECHNOLOGY
 SAN DIEGO, March 26 /PRNewswire/ -- QUIDEL Corp. (NASDAQ: QDEL),


today announced the signing of cross licensing agreements for proprietary technology with Becton Dickinson and Co. (NYSE: BDX)
 In separate agreements the companies exchanged licenses to QUIDEL's specimen delivery technology for immunoassays (U.S. Patent No. 4,818,677, Hay-Kaufman et al.) and to Becton Dickinson's particulate detector technology for immunoassays (U.S. Patent No. 4,703,017, Campbell et. al.)
 "These arrangements add scope to QUIDEL's increasing technology base and will enhance our flow of proprietary and patented products for the rapidly growing immunodiagnostic market," said Scott L. Glenn, QUIDEL's president and chief executive officer.
 QUIDEL Corp. develops, manufactures and markets rapid, immunoassay- based diagnostic products that provide simple, accurate and cost- effective diagnosis in the areas of human fertility, allergy, infectious diseases and autoimmune disorders. These tests are designed for use without instrumentation in the physician's office, clinical laboratory and home testing markets.
 -0- 3/26/92
 /CONTACT: Mark Francois, manager of QUIDEL Investor Relations, 619-552-7931; or Susan Noonan or Anthony J. Russo, of Noonan/Russo Communications, 212-979-9180, for QUIDEL/
 (QDEL BDX) CO: QUIDEL Corp.; Becton Dickinson and Co. ST: California IN: MTC SU: LIC


EH-JL -- SD002 -- 1782 03/26/92 08:04 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 26, 1992
Words:212
Previous Article:COSTCO WHOLESALE ANNOUNCES RECORD OPERATING RESULTS FOR SECOND QUARTER, FIRST HALF OF FISCAL 1992
Next Article:HEALTHINFUSION, INC. ANNOUNCES THE ACQUISITION OF HEALTHCARE SOLUTIONS, INC. OF SOUTHERN CALIFORNIA
Topics:


Related Articles
CELL ANALYSIS SYSTEMS JOINS BECTON DICKINSON
QUIDEL NAMES SCOTT L. GLENN CHAIRMAN/CEO AND STEVEN T. FRANKEL PRESIDENT
QUIDEL AND BECTON DICKINSON EXTEND SUPPLY AGREEMENT BY THREE YEARS
QUIDEL ANNOUNCES MANAGEMENT TRANSITION
QUIDEL AND BECTON DICKINSON SIGN NEW AGREEMENT - QUIDEL ACQUIRES RIGHTS TO CONSUMER FERTILITY PRODUCTS
QUIDEL REPORTS INCREASED SECOND QUARTER SALES; QUIDEL BRANDED PRODUCT SALES INCREASE 30 PERCENT
Baxter: Federal Jury Awards $2.3 Million to Johns Hopkins, Baxter and Becton Dickinson in Patent Infringement Case
QUIDEL Says Becton Dickinson Lawsuit Has No Merit

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters